Europe • Euronext Oslo • OSL:CONTX • SE0014731154
CONTX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 12 industry peers in the Health Care Technology industry. While CONTX has a great profitability rating, there are some minor concerns on its financial health. CONTX is valued expensive and it does not seem to be growing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.07% | ||
| ROE | 3.95% | ||
| ROIC | 2.67% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.9% | ||
| PM (TTM) | 3.17% | ||
| GM | 97.62% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 5.01 | ||
| Altman-Z | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.79 | ||
| Quick Ratio | 4.7 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 78.6 | ||
| Fwd PE | 32.04 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 167.9 | ||
| EV/EBITDA | 19.96 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
ChartMill assigns a fundamental rating of 5 / 10 to CONTX.OL.
ChartMill assigns a valuation rating of 2 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Overvalued.
CONTEXTVISION AB (CONTX.OL) has a profitability rating of 7 / 10.
The financial health rating of CONTEXTVISION AB (CONTX.OL) is 6 / 10.
The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to decline by -103.45% in the next year.